M&T Bank Corp Castle Biosciences Inc Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$16.0 - $45.99 $155,264 - $446,286	-9,704 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$33.17 - $46.98 $321,881 - $455,893	9,704 New	9,704 $436,000
Q4 2021 Feb 07, 2022	SELL	$39.06 - $67.58 $124,445 - $215,309	-3,186 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $138,909 - $232,737	3,186 New	3,186 $214,000

202

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $660M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.